{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Acrylamide : Questions médicales les plus fréquentes",
"headline": "Acrylamide : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Acrylamide : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-03",
"dateModified": "2025-04-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Acrylamide"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Acrylamides",
"url": "https://questionsmedicales.fr/mesh/D000178",
"about": {
"@type": "MedicalCondition",
"name": "Acrylamides",
"code": {
"@type": "MedicalCode",
"code": "D000178",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.241.081.069.094"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Acrylamide",
"alternateName": "Acrylamide",
"code": {
"@type": "MedicalCode",
"code": "D020106",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Fang Chen",
"url": "https://questionsmedicales.fr/author/Fang%20Chen",
"affiliation": {
"@type": "Organization",
"name": "College of Food Science and Nutritional Engineering, National Engineering Research Center for Fruit and Vegetable Processing, Key Laboratory of Fruits and Vegetables Processing, Ministry of Agriculture, Engineering Research Centre for Fruits and Vegetables Processing, Ministry of Education, Beijing Key Laboratory for Food Non-thermal Processing, China Agricultural University, Beijing 100083, China. Electronic address: chenfangch@sina.com."
}
},
{
"@type": "Person",
"name": "Katarzyna Petka",
"url": "https://questionsmedicales.fr/author/Katarzyna%20Petka",
"affiliation": {
"@type": "Organization",
"name": "Department of Plant Products Technology and Nutrition Hygiene, Faculty of Food Technology, University of Agriculture in Krakow, 30-149 Kraków, Poland."
}
},
{
"@type": "Person",
"name": "Aleksandra Duda-Chodak",
"url": "https://questionsmedicales.fr/author/Aleksandra%20Duda-Chodak",
"affiliation": {
"@type": "Organization",
"name": "Department of Fermentation Technology and Microbiology, Faculty of Food Technology, University of Agriculture in Krakow, 30-149 Kraków, Poland."
}
},
{
"@type": "Person",
"name": "Milena Bušová",
"url": "https://questionsmedicales.fr/author/Milena%20Bu%C5%A1ov%C3%A1",
"affiliation": {
"@type": "Organization",
"name": "Institute of Hygiene and Epidemiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic."
}
},
{
"@type": "Person",
"name": "Vladimír Bencko",
"url": "https://questionsmedicales.fr/author/Vladim%C3%ADr%20Bencko",
"affiliation": {
"@type": "Organization",
"name": "Institute of Hygiene and Epidemiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Safe patient handling legislation and musculoskeletal disorders among California healthcare workers: Analysis of workers' compensation data, 2007-2016.",
"datePublished": "2022-05-17",
"url": "https://questionsmedicales.fr/article/35582774",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ajim.23366"
}
},
{
"@type": "ScholarlyArticle",
"name": "Increased Mortality Associated With Disability Among Workers' Compensation Claimants With Upper Extremity Neuropathy.",
"datePublished": "2023-06-23",
"url": "https://questionsmedicales.fr/article/37367631",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/JOM.0000000000002910"
}
},
{
"@type": "ScholarlyArticle",
"name": "Work-related outcomes of revision rotator cuff repair for patients receiving workers' compensation.",
"datePublished": "2023-02-26",
"url": "https://questionsmedicales.fr/article/36849028",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jse.2023.02.014"
}
},
{
"@type": "ScholarlyArticle",
"name": "Workplace Injuries and Receipt of Benefits From Workers' Compensation and Social Security Disability Insurance.",
"datePublished": "2022-10-17",
"url": "https://questionsmedicales.fr/article/36253929",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/JOM.0000000000002728"
}
},
{
"@type": "ScholarlyArticle",
"name": "Respiratory-related workers' compensation claims from private employers - Ohio, 2001-2018.",
"datePublished": "2024-06-21",
"url": "https://questionsmedicales.fr/article/39251271",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jsr.2024.06.004"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Acides carboxyliques",
"item": "https://questionsmedicales.fr/mesh/D002264"
},
{
"@type": "ListItem",
"position": 4,
"name": "Acides acycliques",
"item": "https://questionsmedicales.fr/mesh/D000144"
},
{
"@type": "ListItem",
"position": 5,
"name": "Acrylates",
"item": "https://questionsmedicales.fr/mesh/D000179"
},
{
"@type": "ListItem",
"position": 6,
"name": "Acrylamides",
"item": "https://questionsmedicales.fr/mesh/D000178"
},
{
"@type": "ListItem",
"position": 7,
"name": "Acrylamide",
"item": "https://questionsmedicales.fr/mesh/D020106"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Acrylamide - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Acrylamide",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Acrylamide",
"description": "Comment détecte-t-on l'exposition à l'acrylamide ?\nQuels tests sont utilisés pour évaluer les effets de l'acrylamide ?\nY a-t-il des symptômes spécifiques à l'intoxication par l'acrylamide ?\nComment évaluer les risques liés à l'acrylamide ?\nQuels professionnels peuvent diagnostiquer l'exposition à l'acrylamide ?",
"url": "https://questionsmedicales.fr/mesh/D020106?mesh_terms=Workers'+Compensation&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Acrylamide",
"description": "Quels sont les symptômes d'une exposition aiguë à l'acrylamide ?\nL'acrylamide cause-t-il des effets à long terme ?\nY a-t-il des signes de toxicité chronique ?\nLes symptômes varient-ils selon l'exposition ?\nL'acrylamide affecte-t-il le système nerveux ?",
"url": "https://questionsmedicales.fr/mesh/D020106?mesh_terms=Workers'+Compensation&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Acrylamide",
"description": "Comment réduire l'exposition à l'acrylamide dans l'alimentation ?\nQuels aliments contiennent le plus d'acrylamide ?\nLes réglementations alimentaires limitent-elles l'acrylamide ?\nLes entreprises alimentaires doivent-elles surveiller l'acrylamide ?\nY a-t-il des recommandations pour les consommateurs ?",
"url": "https://questionsmedicales.fr/mesh/D020106?mesh_terms=Workers'+Compensation&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Acrylamide",
"description": "Quel traitement existe pour l'intoxication par l'acrylamide ?\nComment gérer les symptômes neurologiques liés à l'acrylamide ?\nDes antidotes existent-ils pour l'acrylamide ?\nLes patients doivent-ils être hospitalisés ?\nQuels spécialistes peuvent traiter les effets de l'acrylamide ?",
"url": "https://questionsmedicales.fr/mesh/D020106?mesh_terms=Workers'+Compensation&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Acrylamide",
"description": "Quelles sont les complications possibles de l'exposition à l'acrylamide ?\nL'acrylamide peut-il causer des cancers ?\nY a-t-il des effets sur la reproduction liés à l'acrylamide ?\nLes effets de l'acrylamide sont-ils réversibles ?\nComment surveiller les complications liées à l'acrylamide ?",
"url": "https://questionsmedicales.fr/mesh/D020106?mesh_terms=Workers'+Compensation&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Acrylamide",
"description": "Qui est le plus à risque d'exposition à l'acrylamide ?\nLes fumeurs sont-ils plus exposés à l'acrylamide ?\nLes personnes âgées sont-elles plus vulnérables ?\nY a-t-il des prédispositions génétiques à l'acrylamide ?\nLes habitudes alimentaires influencent-elles le risque d'acrylamide ?",
"url": "https://questionsmedicales.fr/mesh/D020106?mesh_terms=Workers'+Compensation&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment détecte-t-on l'exposition à l'acrylamide ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exposition peut être évaluée par des tests biologiques mesurant l'acrylamide dans l'urine."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les effets de l'acrylamide ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et urinaires peuvent évaluer les niveaux d'acrylamide et ses métabolites."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques à l'intoxication par l'acrylamide ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des troubles neurologiques, mais ils ne sont pas spécifiques."
}
},
{
"@type": "Question",
"name": "Comment évaluer les risques liés à l'acrylamide ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation des risques se fait par des études épidémiologiques et des analyses toxicologiques."
}
},
{
"@type": "Question",
"name": "Quels professionnels peuvent diagnostiquer l'exposition à l'acrylamide ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les médecins spécialisés en médecine du travail et en toxicologie peuvent diagnostiquer l'exposition."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une exposition aiguë à l'acrylamide ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des maux de tête, des nausées et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "L'acrylamide cause-t-il des effets à long terme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut entraîner des neuropathies et des effets cancérogènes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes de toxicité chronique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes de toxicité chronique incluent des troubles moteurs et des problèmes cognitifs."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'exposition ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes dépendent de la durée et du niveau d'exposition à l'acrylamide."
}
},
{
"@type": "Question",
"name": "L'acrylamide affecte-t-il le système nerveux ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'acrylamide peut causer des dommages au système nerveux central et périphérique."
}
},
{
"@type": "Question",
"name": "Comment réduire l'exposition à l'acrylamide dans l'alimentation ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez de cuire les aliments à haute température et privilégiez les méthodes de cuisson douces."
}
},
{
"@type": "Question",
"name": "Quels aliments contiennent le plus d'acrylamide ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les aliments frits, grillés ou cuits au four, comme les pommes de terre, contiennent souvent de l'acrylamide."
}
},
{
"@type": "Question",
"name": "Les réglementations alimentaires limitent-elles l'acrylamide ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, plusieurs pays ont mis en place des réglementations pour limiter l'acrylamide dans les aliments."
}
},
{
"@type": "Question",
"name": "Les entreprises alimentaires doivent-elles surveiller l'acrylamide ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les entreprises doivent surveiller et réduire les niveaux d'acrylamide dans leurs produits."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations pour les consommateurs ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les consommateurs sont conseillés de diversifier leur alimentation et de limiter les aliments frits."
}
},
{
"@type": "Question",
"name": "Quel traitement existe pour l'intoxication par l'acrylamide ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement spécifique, mais des soins symptomatiques peuvent être fournis."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes neurologiques liés à l'acrylamide ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion peut inclure des thérapies physiques et des médicaments pour soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour l'acrylamide ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique pour l'acrylamide, le traitement est symptomatique."
}
},
{
"@type": "Question",
"name": "Les patients doivent-ils être hospitalisés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hospitalisation dépend de la gravité des symptômes et de l'exposition à l'acrylamide."
}
},
{
"@type": "Question",
"name": "Quels spécialistes peuvent traiter les effets de l'acrylamide ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les neurologues et les toxicologues sont souvent impliqués dans le traitement des effets de l'acrylamide."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de l'exposition à l'acrylamide ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles neurologiques, des cancers et des problèmes de reproduction."
}
},
{
"@type": "Question",
"name": "L'acrylamide peut-il causer des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'acrylamide est classé comme cancérogène potentiel par certaines agences de santé."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets sur la reproduction liés à l'acrylamide ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent que l'acrylamide peut affecter la fertilité et le développement fœtal."
}
},
{
"@type": "Question",
"name": "Les effets de l'acrylamide sont-ils réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains effets peuvent être réversibles, mais d'autres, comme les dommages nerveux, peuvent être permanents."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications liées à l'acrylamide ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La surveillance se fait par des examens médicaux réguliers et des évaluations neurologiques."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque d'exposition à l'acrylamide ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs dans l'industrie chimique et alimentaire sont les plus à risque d'exposition."
}
},
{
"@type": "Question",
"name": "Les fumeurs sont-ils plus exposés à l'acrylamide ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente l'exposition à l'acrylamide en raison de sa présence dans la fumée."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus vulnérables ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent être plus vulnérables aux effets de l'acrylamide en raison de la santé générale."
}
},
{
"@type": "Question",
"name": "Y a-t-il des prédispositions génétiques à l'acrylamide ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines variations génétiques peuvent influencer la métabolisation de l'acrylamide, augmentant le risque."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles le risque d'acrylamide ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en aliments frits et grillés augmente le risque d'exposition à l'acrylamide."
}
}
]
}
]
}
California requires general acute care hospitals to have a comprehensive plan to prevent patient handling injuries (PHIs) among employees. The California safe patient handling (SPH) law took effect in...
We used California Workers' Compensation Information System data from 2007 to 2016 and analyzed claims for MSDs that occurred in acute care hospitals compared with nursing and residential care facilit...
We identified 199,547 MSD claims that occurred during 2007-2016 in acute care hospitals (62.8%) and nursing and residential care facilities (37.2%). MSDs accounted for 42.8% of all claims. Of the MSD ...
Our study identified significant reductions of PHI claims among California hospital workers after the passage of the SPH legislation, suggesting that SPH legislation played a crucial role in reducing ...
The aim of the study was to evaluate and compare mortality after disabling and nondisabling occupational injuries....
Vital status was ascertained through 2020 for 2077 individuals with a workers' compensation claim for upper extremity neuropathy in West Virginia in 1998 or 1999. Standardized mortality ratios compare...
Overall, the standardized mortality ratio for accidental poisoning deaths was elevated (1.75, 95% confidence interval [CI]: 1.08-2.68). All-cause mortality HRs and cancer HRs were elevated for lost wo...
Work-related disability was associated with broad elevations in mortality....
Workers' compensation (WC) patients are susceptible to poorer outcomes following primary rotator cuff repair (RCR). Failure of structural healing can explain some poor results, and outcomes of revisio...
A retrospective review was performed of individuals receiving WC who underwent arthroscopic revision RCR with or without dermal allograft augmentation at a single institution between January 2010 and ...
Twenty-seven shoulders (25 patients) were included. The population was 84% male, with a mean age of 54 years; 67% were manual laborers, 11% sedentary workers, and 22% with a mixed profession. Average ...
Workers' compensation patients demonstrated fair improvements in outcome scores after revision RCR. Although some patients are able to return to full duty, nearly half were either unable to return or ...
We examine whether workers who experience permanently disabling injuries covered by workers' compensation (WC) end up on Social Security Disability Insurance (SSDI) and whether Social Security Adminis...
Diseases and conditions related to the respiratory system contribute to work-related morbidity, mortality, and disability. Details on the causes and nature of work-related respiratory disease and the ...
We developed a list of respiratory-related International Classification of Diseases Clinical Modification (ICD-CM) diagnosis codes and searched over 2 million claims filed between 2001 and 2018 in the...
Among the 23,015 respiratory-related claims (5.8 per 10,000 full-time equivalents [FTE]), 54.6% had at least one ICD-CM code for Allergic Reactions and 30.6% had at least one code for Toxic Effects of...
Respiratory-related claims in the OHBWC system were often acute in nature and included allergic reactions. Narratives from these claims provide insight into the work-related exposures and events causi...
Efficacy of a neurocognitive screening evaluation (NCSE) in assessing symptoms and disability associated with post-COVID-19 condition (PCC) and facilitating employee recovery and return to work was ev...
An NCSE was administered to 64 employees off work because of neurocognitive complaints attributed to post-COVID-19 condition. Neurocognitive and symptom validity data were analyzed along with recovery...
A large percentage of the employees gave invalid responses and noncredible effort on psychological and cognitive tests (48%). The NCSEs with invalid profiles suggested more severe cognitive and psychi...
Post-COVID-19 condition resulted in reports of mild to moderate cognitive and psychiatric symptoms with extensive mean work leave of 11 months before mental health assessment. Regardless of symptom va...
In 2015, South Australia replaced its workers' compensation system with the aim of improving return to work rates. We examined whether this was achieved by focusing on the duration of time off work, a...
The primary outcome was mean weeks of compensated disability duration. Secondary outcomes tested alternative mechanisms of a change in disability duration: (1) mean employer report and insurer decisio...
While disability duration steadily declined before the...
The increase in disability duration after the...
Low back pain (LBP) is a leading cause of disability globally and interferes with work performance and quality of life. For work-related LBP, Australian workers can receive workers' compensation and a...
Claims and services data from four Australian workers' compensation jurisdictions were analysed. Prevalence of accessing at least one mental health service was reported as a percentage of all claims o...
Almost 10% of LBP claims accessed at least one mental health service (9.7%) with prevalence increasing with time loss. Prevalence was highest in Victoria however a higher percentage of workers with LB...
Findings suggest opportunities for workers' compensation regulators and insurers to provide greater access to appropriate mental health services alongside physical treatment as standard practice, such...
Vermont has high rates of young people receiving federal disability benefits leading to substantial gaps in the workforce. The purpose of this project was to determine the unmet needs of interested pa...
A type of focus group, experience groups, was used to elicit key parties' experiences in the WC system. Facilitators used open-ended prompts to encourage discussion among participants about their expe...
Common themes emerged including challenges in navigating the WC system, lack of communication among stakeholders, and providing and receiving appropriate health care to facilitate RTW....
Understanding unmet needs of interested parties in the WC process allows for the creation of targeted, high-value, early intervention strategies to reduce long-term work disability....
This study aimed to characterize the distribution and award status of COVID-19-related workers' compensation (WC) claims in New York State (NYS) for 2020 and 2021....
Characteristics and filing rates of COVID-19 claims were described by industry, time of illness, and award status. Nursing care facilities' claims were compared with the recorded nursing home staff CO...
Of 29,814 COVID-19 claims, 21.9% were awarded benefits, although 86.8% of the claimants worked in essential industries. Of the 46,505 CMS-recorded COVID-19 infections, 1.4% resulted in a claim and 7.2...
The NYS WC program has provided very modest support to essential workers for the likely work-related burden of the pandemic in NYS....